Navigation Links
Gallbladder shown as potential stem cell source for regenerative liver and metabolic disease
Date:4/19/2012

A new study presented today at the International Liver Congress 2012 indicates the potential for gallbladder tissue (which is routinely discarded from organ donors and surgical interventions) to be a highly available candidate source for multipotential stem cells.(1)

Biliary tree stem/progenitor cells (BTSCs) have previously been identified in the glands of normal adult human extrahepatic bile ducts and been shown to generate in vitro and in vivo mature cells of the hepato-biliary and pancreatic endocrine lineages.

The study found both normal and pathological gallbladders contained easily isolable cells with the phenotype and biological properties of BTSCs. Interestingly, in an animal model, these cells were able to repopulate the injured liver and to improve synthetic functions.

These data open novel perspectives for the collection and use of multipotent stem cells in regenerative therapies of liver, bile duct, and pancreatic diseases including diabetes


'/>"/>

Contact: Travis Taylor
easlpressoffice@cohnwolfe.com
44-789-438-6428
European Association for the Study of the Liver
Source:Eurekalert

Page: 1

Related biology news :

1. Gallbladder cancer may be linked to estrogens, says UH team
2. Robo-surgery: As safe and capable as a human assistant in key-hole gallbladder removal
3. Pycnogenol (French maritime pine bark extract) shown to improve menopause symptoms in new study
4. Cardiac MRI shown to improve diagnosis in patients with life-threatening arrhythmias
5. Pycnogenol (French maritime pine bark extract) shown to improve visible signs of aging in new study
6. Head-first diversity shown to drive vertebrate evolution
7. Evolution and domestication of seed structure shown to use same genetic mutation
8. AIDS drug shown to prevent HIV in multinational trial of HIV-negative gay men
9. Scented consumer products shown to emit many unlisted chemicals
10. Valproic acid shown to halt vision loss in patients with retinitis pigmentosa
11. Promising results shown for kidney cancer drug
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/12/2017)... 12, 2017  Trovagene, Inc. (NASDAQ: TROV ... today announced that it has signed agreements with seven ... the Middle East for commercialization ... the first wave of international distribution agreements for Trovagene,s ... samples. The initial partners will introduce Trovagene,s ...
(Date:1/11/2017)... DES MOINES, Iowa , Jan. 11, 2017 /PRNewswire/ ... another industry first with the release of its patent-pending ... to quickly and reliably perform calibrations, securely upload data ... more flexibility for the customer. "Fighting drunk ... not only for the public at large, but also ...
(Date:1/6/2017)... 5, 2017  SomaLogic announced today that it ... established by iCarbonX, the China ... "Global Digital Health Ecosystem that can define each ... individual,s biological, behavioral and psychological data, the Internet ... companies, SomaLogic will provide proteomics data and applications ...
Breaking Biology News(10 mins):
(Date:1/18/2017)... , ... January 18, 2017 , ... ... essential device-to-computer interconnect using USB or PCI Express, announced the ZEM5310 USB 3.0 ... E FPGA into a compact business-card sized form factor suitable for prototyping, testing, ...
(Date:1/18/2017)... , ... January 18, 2017 , ... ... Clinical Ops Executives 2017 in its continued commitment to the advancement of the ... to discuss current issues related to clinical trial planning and management. , ...
(Date:1/18/2017)... ... ... a new study are stating that if levels of the blood test called prostate ... is still remaining prostate cancer cells that are more likely to come back, spreading and ... indicator of whether a man’s prostate cancer is growing or not,” stated Dr. Samadi. ...
(Date:1/18/2017)... 18, 2017 Shareholder rights law firm Johnson ... the board members of CoLucid Pharmaceuticals, Inc. (NASDAQ: ... with the proposed sale of the Company to Eli ... develops small molecules for the acute treatment of migraines. ... had signed a definitive merger agreement with Eli Lilly. ...
Breaking Biology Technology: